Hennie Geldenhuys

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2019
Publications (10 Years): 1

Top Topics

Human Immunodeficiency Virus

Placebo Controlled

Squamous Cell Carcinoma

Top Venues

American journal of respiratory and critical care medicine

University of Cape Town

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Cape Town

South Africa

Clinical Researcher :: South African Tuberculosis Vaccine Initiative

Publications

Sara A Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, Michele Tameris, Soren T Hoff, Zhongkai Shi, Dereck Tait, Ingrid Kromann, Morten Ruhwald, Kathryn Tucker Rutkowski, Barbara Shepherd, David Hokey, Ann M Ginsberg, Willem A Hanekom, Peter Andersen, Thomas Jens Scriba, Mark Hatherill, null null
Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial. American journal of respiratory and critical care medicine 199 (2) (2019)